Larimar Therapeutics

Larimar Therapeutics Advances Nomlabofusp Clinical Program with First Patient Dosed in Open Label Extension Study

BALA CYNWYD, PA — Clinical-stage biotechnology company Larimar Therapeutics, Inc. (Nasdaq: LRMR) has announced the dosing of the first patient in an open label extension (OLE) study for its novel …

Larimar Therapeutics Advances Nomlabofusp Clinical Program with First Patient Dosed in Open Label Extension Study Read More



Chrissy Houlahan

Rep. Houlahan Secures Over $11.7 Million in Community Project Funding for Southern Berks and Chester Counties

WASHINGTON, D.C. —  Representative Chrissy Houlahan (D-PA) has successfully secured the funding of 14 Community Project Funding priorities, amassing a whopping $11,726,065 through the House Appropriations Committee. This remarkable initiative …

Rep. Houlahan Secures Over $11.7 Million in Community Project Funding for Southern Berks and Chester Counties Read More